Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 4 Open-market buy 10% owner bought 832,456 shares at $12,786,524.16 ($10,644,218,756,137)
  2. 4 Grant or award Director acquired 23,133 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award SVP and CFO acquired 102,471 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Shares withheld for taxes Sr. VP, Technical Operations gave up 3,261 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP, Research & Early Clin Dev gave up 3,261 shares (to pay taxes)
  8. 4 Shares withheld for taxes Sr VP, Gen. Counsel, Secretary gave up 3,261 shares (to pay taxes)
  9. 4 Shares withheld for taxes Sr VP, Chief Comm. Officer gave up 3,261 shares (to pay taxes)
  10. 4 Returned to the company Director returned 96,250 shares (to the company)
  11. 4 Grant or award President & CEO acquired 43,905 shares (grant or award)
  12. 4 Open-market sale Sr. VP, Technical Operations sold 53,424 shares at $22.50 ($1,202,040)
  13. 4 Open-market sale Sr VP, Gen. Counsel, Secretary sold 28,156 shares at an average $22.13 ($622,999)
  14. 4 Open-market buy 10% owner bought 172,651 shares at $3,912,271.66 ($675,457,614,371)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Sr. VP, Corp. Partnerships acquired 10,000 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 62,403 shares (grant or award)
  19. 4 Grant or award Sr VP, Gen. Counsel, Secretary acquired 28,365 shares (grant or award)
  20. 4 Grant or award SVP, Research & Early Clin Dev acquired 28,365 shares (grant or award)

Page 15 of 39 · 776 filings